
Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. (KZR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KZR · as of Jun 9, 2026
Key Statistics
Explore Kezar Life Sciences, Inc. Data
kzr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 28.6%
The KZR analyst consensus is Hold, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $11.00, representing +50.89% upside from the current price of $7.29.
Competitors & Peers
kzr competitorsStock Performance
Full HistoryAbout Kezar Life Sciences, Inc.
Kezar Life Sciences, Inc. is a United States-based clinical-stage biopharmaceutical company focused on identifying and advancing novel small molecule therapies. Its mission is to address significant u…
what is kezar life sciences, inc. · kzr stock overview · kezar life sciences, inc. company profile · who is kezar life sciences, inc. ceo · kzr NASDAQ · kezar life sciences, inc. headquarters · kezar life sciences, inc. business segments
About Stock Overview & Key Data
Kezar Life Sciences, Inc. (KZR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 21, 2018. As of the latest trading session, KZR stock price is $7.29, with a market capitalization of $53.9M. The stock has returned +63.82% over the past 12 months and +15.90% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Kezar Life Sciences, Inc. stock is Hold, with an average 12-month price target of $11.00. In fiscal year 2025, Kezar Life Sciences, Inc. reported revenue of — and net income of -$56.0M. For detailed data — including Kezar Life Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kezar Life Sciences, Inc. (KZR) stock price is $7.29. The stock is traded on NASDAQ under the ticker symbol KZR. The 52-week range is $3.53 – $7.55.